Report Detail
Global GERD Market Size, Status and Forecast 2019-2025
- RnM3411290 |
- 16 July, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Other
Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and esophagus. It occurs when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the esophagus and causes GERD. It affects all ages from infants to older adults. The symptoms of GERD include difficulty while swallowing (dysphagia), heartburn sensation, regurgitation or acid reflux, dry cough, sore throat, and chest pain.
The antacids segment to account for more than 58% of the total market share during the forecast period. This segment consists of drugs that contain weak bases. These bases react with stomach acids to neutralize and release salt and water.
The oral route of drug administration to be the most preferred route of drug administration during the forecast period. The drugs administered through this route have to undergo first-pass metabolism and can be administered as tablets, capsules, and oral liquids. This route’s high degree of safety will result in its augmented preference during the forecast period.
In 2018, the global GERD market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global GERD status, future forecast, growth opportunity, key market and key players. The study objectives are to present the GERD development in United States, Europe and China.
The key players covered in this study
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda
CJ Cheil Jedang
Daewoong Pharmaceutical
SFJ Pharmaceuticals Group
Vecta Pharmaceuticals
Zeria Pharmaceuticals
Market segment by Type, the product can be split into
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
Other
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global GERD status, future forecast, growth opportunity, key market and key players.
To present the GERD development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of GERD are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global GERD Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Proton Pumps Inhibitors
- 1.4.3 H2 Receptor Antagonists
- 1.4.4 Antacids
- 1.4.5 Prokinetics
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global GERD Market Share by Application (2014-2025)
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 GERD Market Size
- 2.2 GERD Growth Trends by Regions
- 2.2.1 GERD Market Size by Regions (2014-2025)
- 2.2.2 GERD Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 GERD Market Size by Manufacturers
- 3.1.1 Global GERD Revenue by Manufacturers (2014-2019)
- 3.1.2 Global GERD Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global GERD Market Concentration Ratio (CR5 and HHI)
- 3.2 GERD Key Players Head office and Area Served
- 3.3 Key Players GERD Product/Solution/Service
- 3.4 Date of Enter into GERD Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global GERD Market Size by Type (2014-2019)
- 4.2 Global GERD Market Size by Application (2014-2019)
5 United States
- 5.1 United States GERD Market Size (2014-2019)
- 5.2 GERD Key Players in United States
- 5.3 United States GERD Market Size by Type
- 5.4 United States GERD Market Size by Application
6 Europe
- 6.1 Europe GERD Market Size (2014-2019)
- 6.2 GERD Key Players in Europe
- 6.3 Europe GERD Market Size by Type
- 6.4 Europe GERD Market Size by Application
7 China
- 7.1 China GERD Market Size (2014-2019)
- 7.2 GERD Key Players in China
- 7.3 China GERD Market Size by Type
- 7.4 China GERD Market Size by Application
8 Japan
- 8.1 Japan GERD Market Size (2014-2019)
- 8.2 GERD Key Players in Japan
- 8.3 Japan GERD Market Size by Type
- 8.4 Japan GERD Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia GERD Market Size (2014-2019)
- 9.2 GERD Key Players in Southeast Asia
- 9.3 Southeast Asia GERD Market Size by Type
- 9.4 Southeast Asia GERD Market Size by Application
10 India
- 10.1 India GERD Market Size (2014-2019)
- 10.2 GERD Key Players in India
- 10.3 India GERD Market Size by Type
- 10.4 India GERD Market Size by Application
11 Central & South America
- 11.1 Central & South America GERD Market Size (2014-2019)
- 11.2 GERD Key Players in Central & South America
- 11.3 Central & South America GERD Market Size by Type
- 11.4 Central & South America GERD Market Size by Application
12 International Players Profiles
- 12.1 AstraZeneca
- 12.1.1 AstraZeneca Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 GERD Introduction
- 12.1.4 AstraZeneca Revenue in GERD Business (2014-2019)
- 12.1.5 AstraZeneca Recent Development
- 12.2 Eisai
- 12.2.1 Eisai Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 GERD Introduction
- 12.2.4 Eisai Revenue in GERD Business (2014-2019)
- 12.2.5 Eisai Recent Development
- 12.3 GlaxoSmithKline
- 12.3.1 GlaxoSmithKline Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 GERD Introduction
- 12.3.4 GlaxoSmithKline Revenue in GERD Business (2014-2019)
- 12.3.5 GlaxoSmithKline Recent Development
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 GERD Introduction
- 12.4.4 Johnson & Johnson Revenue in GERD Business (2014-2019)
- 12.4.5 Johnson & Johnson Recent Development
- 12.5 Takeda
- 12.5.1 Takeda Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 GERD Introduction
- 12.5.4 Takeda Revenue in GERD Business (2014-2019)
- 12.5.5 Takeda Recent Development
- 12.6 CJ Cheil Jedang
- 12.6.1 CJ Cheil Jedang Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 GERD Introduction
- 12.6.4 CJ Cheil Jedang Revenue in GERD Business (2014-2019)
- 12.6.5 CJ Cheil Jedang Recent Development
- 12.7 Daewoong Pharmaceutical
- 12.7.1 Daewoong Pharmaceutical Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 GERD Introduction
- 12.7.4 Daewoong Pharmaceutical Revenue in GERD Business (2014-2019)
- 12.7.5 Daewoong Pharmaceutical Recent Development
- 12.8 SFJ Pharmaceuticals Group
- 12.8.1 SFJ Pharmaceuticals Group Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 GERD Introduction
- 12.8.4 SFJ Pharmaceuticals Group Revenue in GERD Business (2014-2019)
- 12.8.5 SFJ Pharmaceuticals Group Recent Development
- 12.9 Vecta Pharmaceuticals
- 12.9.1 Vecta Pharmaceuticals Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 GERD Introduction
- 12.9.4 Vecta Pharmaceuticals Revenue in GERD Business (2014-2019)
- 12.9.5 Vecta Pharmaceuticals Recent Development
- 12.10 Zeria Pharmaceuticals
- 12.10.1 Zeria Pharmaceuticals Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 GERD Introduction
- 12.10.4 Zeria Pharmaceuticals Revenue in GERD Business (2014-2019)
- 12.10.5 Zeria Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on GERD. Industry analysis & Market Report on GERD is a syndicated market report, published as Global GERD Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of GERD market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
